Delivery Order SPE2DB22D1106-SPE2DB24FFMX1

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract, valued at $54,219.00, is a firm fixed-price delivery order that runs through December 13, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of M-M-R II vaccine vials. The contract has a ceiling value of $1,107.78 and a period of performance through March 14, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide M-M-R II vaccine vials. The contract has a ceiling value of $3,879.08 and is a Firm Fixed Price Delivery Order. It runs through July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,901.60 firm fixed-price award is for the supply of M-M-R II vaccine vials, with a completion date of July 22, 2022. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,661.67, is for the delivery of M-M-R II vaccine vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 17, 2025. It is not designated as a set-aside contract. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical supplier, for the delivery of M-M-R II vaccine vials. The contract, valued at $5,248.20, is a Firm Fixed Price Delivery Order with a completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office division, will supply the vaccines to support military treatment facilities and other federal healthcare programs. The contract is not set...
This federal contract award, valued at $11,531.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials, with a completion date of March 26, 2025. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,022.91 fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance through March 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of M-M-R II vaccine vials. The $7,382.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on October 16, 2024, with a completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,763.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials, a critical medical product used for infectious disease prevention. The contract has a period of performance through March 17, 2025 and is structured as a firm fixed-price delivery order, with no set-aside designation indicated....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFMX1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of M-M-R II vaccine vials. The contract, valued at $36,245.43, is a Firm Fixed Price Delivery Order with a period of performance ending on September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply the critical vaccine to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of medical commodities to various federal agencies and healthcare facilities.

Generated 12/17/24, 9:31 AM